Literature DB >> 18492617

Pregabalin-induced cortical negative myoclonus in a patient with neuropathic pain.

Sabine Hellwig, Florian Amtage.   

Abstract

Myoclonus is a well-known side effect of anticonvulsant drugs. Pregabalin is one of the newer drugs approved for the treatment of focal epilepsies. Frequently it is also used to treat chronic pain syndromes. We describe a patient who, after receiving his first dose of pregabalin to relieve neuropathic pain, presented with a negative myoclonus. Clinical aspects and electrophysiological data such as polygraphic studies, electroencephalography, and measurement of somatosensory evoked potentials support the cortical origin of negative myoclonus. Our findings reveal that even in patients without a history of seizures, pregabalin can cause a cortical negative myoclonus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18492617     DOI: 10.1016/j.yebeh.2008.04.006

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  5 in total

1.  Delayed onset of rotatory self-motion perception, dysdiadochokinesia and disturbed eye pursuit caused by low-dose pregabalin.

Authors:  Patrice Hounnou; Keyvan Nicoucar
Journal:  BMJ Case Rep       Date:  2014-04-11

2.  Resolution of pregabalin and mirtazapine associated restless legs syndrome by bupropion in a patient with major depressive disorder.

Authors:  Young-Min Park; Heon-Jeong Lee; Seung-Gul Kang; Jae-Hyuck Cho; Leen Kim
Journal:  Psychiatry Investig       Date:  2009-11-19       Impact factor: 2.505

3.  Pregabalin for the management of partial epilepsy.

Authors:  Philippe Ryvlin; Emilio Perucca; Sylvain Rheims
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

4.  Pregabalin-associated myoclonic encephalopathy without evidence of drug accumulation in a patient with acute renal failure.

Authors:  F Courtois; D Borrey; V Haufroid; P Hantson
Journal:  Indian J Nephrol       Date:  2014-01

5.  Negative myoclonus associated with pregabalin.

Authors:  Kwan-Do Park; Min-Ku Kim; Se-Jin Lee
Journal:  Yeungnam Univ J Med       Date:  2018-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.